Association of the metabolic syndrome with intracranial atherosclerotic stroke
- 26 July 2005
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 65 (2) , 296-298
Abstract
To investigate the impact of metabolic syndrome (MetSD) on the development of intracranial atherosclerotic stroke, the authors evaluated the components of the MetSD in 512 patients with stroke. The MetSD was observed most frequently in patients with intracranial atherosclerosis (p = 0.007). In multiple regression analysis, the MetSD, but not conventional risk factors, was independently associated with intracranial atherosclerosis (p = 0.005). The results suggest that treatment of metabolic abnormalities may be an important prevention strategy for intracranial atherosclerosis.Keywords
This publication has 7 references indexed in Scilit:
- The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)The American Journal of Cardiology, 2004
- The Metabolic Syndrome and Antioxidant ConcentrationsDiabetes, 2003
- Plasma Lipid Profile and Incident Ischemic StrokeStroke, 2003
- Age-Related Effects on Atherogenesis and Scavenger Enzymes of Intracranial and Extracranial Arteries in Men Without Classic Risk Factors for Atherosclerosis Editorial CommentStroke, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Clustering of Procoagulation, Inflammation, and Fibrinolysis Variables with Metabolic Factors in Insulin Resistance SyndromeAmerican Journal of Epidemiology, 2000
- Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant StressCirculation Research, 2000